Live Chat Software
February 10, 2022 • 1:00 PM - 2:00 PM ET
The way patients and healthcare providers (HCPs) interact with life sciences organizations, each other and other specialty pharma players has drastically evolved over the past two years. COVID-19 and new market entrants served as catalysts for change that affected the needs and expectations among patients and HCPs. We’ve seen increased virtual and cloud-based tools, as well as innovative patient solutions models.
The question for you is: How is your organization keeping up with changing patient and HCP expectations?
To ensure your patient solutions program is embracing the right solutions to meet your unique patient and HCP populations, we invite you to join our experts—AssistRx President and CEO Jeff Spafford and Patient Solutions Division President Jan Nielsen—as they :
- Discuss how patient and healthcare provider expectations have changed in the past two years
- Determine which solutions and technologies are addressing these changing expectations
- Understand what these developments mean for patient support programs
Webinar Speakers
Bridget Brennan
|
Bridget Brennan
Sr. Director of Marketing & Communications AssistRx |
Jan Nielsen
|
Jan Nielsen
AssistRx Patient Solutions Division President AssistRx |
Jan Nielsen directs strategy and operations for the AssistRx Patient Solutions portfolio, including the access and patient support services and the non-commercial pharmacy, as well as the quality and corporate training departments. In her role, she leads with more than 30 years of experience as a clinical and operational subject matter expert with a strong background in critical care, hospital management and specialty pharmaceutical commercialization services. Her proven track record driving innovation within the specialty pharmaceutical industry supports AssistRx’s unique approach to combining technology and talent to improve patient access and treatment outcomes.
Prior to joining AssistRx, Nielsen served as a senior principal at Blue Fin Group, a management and technology consulting firm with a focus on the pharmaceutical, biotechnology and healthcare industries. Prior to Blue Fin Group, Nielsen was the division president of access and patient support for Sonexus, a Cardinal Health company, where she founded and launched the patient support services business unit. Her industry leadership also includes leading the development and launch of the clinical support division of AmerisourceBergen that now resides with Lash Group.
Nielsen earned a master’s degree in public administration and a bachelor’s degree in human services from Notre Dame de Namur University. She received her nursing degree from the U.S. Army School of Nursing
Jeff Spafford
|
Jeff Spafford
Co-Founder, President and CEO AssistRx |
Jeff Spafford has served as AssistRx President and CEO since co-founding the firm with Edward Hensley in 2009. Spafford has more than 20 years of experience in leadership roles within the specialty pharmaceutical industry.
In 1998, Spafford established OncoScripts, one of the first specialty pharmacies. OncoScripts developed a chemotherapy drug management model and contracted directly with large, national payers. OncoScripts was soon acquired by CuraScript, a Florida-based specialty pharmacy with a mission to oversee specialty drugs on behalf of managed care payers. In 2001, he relocated to Central Florida and transitioned into his new role as executive vice president for CuraScript, in which he was responsible for sales and marketing.
In 2005, Spafford co-founded and served as president and CEO of Advanced Care Scripts. After three successful years, he sold the company and shifted management of the business to Omnicare. In 2009, he co-founded AssistRx with the mission to deliver leading technology and people solutions that connect every stakeholder in the specialty therapy journey. AssistRx solutions accelerate patient access to therapy and improve outcomes.
Spafford earned a bachelor’s degree in economics from St. Lawrence University and a Master of Business Administration from Harvard Business School.
AssistRX
AssistRx has engineered the perfect blend of technology and talent to provide manufacturers with an efficient solution to improve patient uptake, visibility and outcomes. Our specialty therapy initiation and patient support solution delivers informed touchpoints, simplifying a complex system to enable better results for today’s patients.